A Review of Evolving Dialysis Catheter Technologies

ABSTRACT

Dialysis catheters continue to play a vital role in the delivery of hemodialysis to patients for both temporary vascular access, serving as a bridge to permanent access, and for long-term access for patients with end-stage renal disease (ESRD). During the past decade, there has been an emergence of technological advancements in the design of dialysis catheters in an attempt to reduce catheter malfunction, decrease infection rates, and improve their long-term efficiency. New improvements in catheter design are aimed at translating into improved catheter performance. This review article summarizes some of the novel catheter designs developed within the last decade.

KEYWORDS

Dialysis - end-stage renal disease - catheters - tunneled catheters

REFERENCES

• 1 Anonymous . III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000.  Am J Kidney Dis. 2001;  37(1, Suppl 1) S137-S181
• 2 Tokars J I, Frank M, Alter M J, Arduino M J. National surveillance of dialysis-associated diseases in the United States, 2000.  Semin Dial. 2002;  15(3) 162-171
• 3 U.S. Renal Data System .USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD; National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2008
• 4 Willms L, Vercaigne L M. Does warfarin safely prevent clotting of hemodialysis catheters? A review of efficacy and safety.  Semin Dial. 2008;  21(1) 71-77
• 5 Watnick S, Stooksbury M, Winter R, Riscoe M, Cohen D M. White thrombus formation in blood tubing lines in a chronic hemodialysis unit.  Clin J Am Soc Nephrol. 2008;  3(2) 382-386
• 6 Lénárd L, Szabados S, Imre J et al.. [Vena cava superior syndrome: surgical treatment of the thrombosis of the superior vena cava after implantation of a hemodialysis catheter—a case report and review of the literature].  Orv Hetil. 2008;  149(1) 29-34
• 7 Solomon D D, Arnold W L, Martin N D, Lentz D J. An in vivo method for the evaluation of catheter thrombogenicity.  J Biomed Mater Res. 1987;  21(1) 43-57
• 8 Sherertz R J, Carruth W A, Marosok R D, Espeland M A, Johnson R A, Solomon D D. Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo.  J Biomed Mater Res. 1995;  29(5) 635-645
• 9 Tal M G, Ni N. Selecting optimal hemodialysis catheters: material, design, advanced features, and preferences.  Tech Vasc Interv Radiol. 2008;  11(3) 186-191
• 10 Atherikul K, Schwab S J, Conlon P J. Adequacy of haemodialysis with cuffed central-vein catheters.  Nephrol Dial Transplant. 1998;  13(3) 745-749
• 11 Mickley V. Central venous catheters: many questions, few answers.  Nephrol Dial Transplant. 2002;  17(8) 1368-1373
• 12 Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.  J Am Soc Nephrol. 1998;  9(5) 869-876
• 13 Nielsen J, Ladefoged S D, Kolmos H J. Dialysis catheter-related septicaemia—focus on Staphylococcus aureus septicaemia .  Nephrol Dial Transplant. 1998;  13(11) 2847-2852
• 14 Marr K A, Sexton D J, Conlon P J, Corey G R, Schwab S J, Kirkland K B. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis.  Ann Intern Med. 1997;  127(4) 275-280
• 15 Dhingra R K, Young E W, Hulbert-Shearon T E, Leavey S F, Port F K. Type of vascular access and mortality in U.S. hemodialysis patients.  Kidney Int. 2001;  60(4) 1443-1451
• 16 Hung K Y, Tsai T J, Yen C J, Yen T S. Infection associated with double lumen catheterization for temporary haemodialysis: experience of 168 cases.  Nephrol Dial Transplant. 1995;  10(2) 247-251
• 17 McCarthy M C, Shives J K, Robison R J, Broadie T A. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition.  JPEN J Parenter Enteral Nutr. 1987;  11 259-262
• 18 Maki D G, Stolz S M, Wheeler S, Mermel L A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.  Ann Intern Med. 1997;  127(4) 257-266
• 19 Greenfeld J I, Sampath L, Popilskis S J, Brunnert S R, Stylianos S, Modak S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine.  Crit Care Med. 1995;  23(5) 894-900
• 20 Schwab S J, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't live without them.  Kidney Int. 1999;  56(1) 1-17
• 21 Fan P Y. Acute vascular access: new advances.  Adv Ren Replace Ther. 1994;  1(2) 90-98
• 22 Schwab S J, Buller G L, McCann R L, Bollinger R R, Stickel D L. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use.  Am J Kidney Dis. 1988;  11(2) 166-169
• 23 Twardowski Z. High dose intradialytic urokinase to restore patency of permanent central vein hemodialysis catheters.  Am J Kidney Dis. 1998;  31(5) 841-847
• 24 Dryden M S, Samson A, Ludlam H A, Wing A J, Phillips I. Infective complications associated with the use of the Quinton ‘Permcath’ for long-term central vascular access in haemodialysis.  J Hosp Infect. 1991;  19(4) 257-262
• 25 Maki D G, Cobb L, Garman J K, Shapiro J M, Ringer M, Helgerson R B. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial.  Am J Med. 1988;  85(3) 307-314
• 26 Flowers III R H, Schwenzer K J, Kopel R F, Fisch M J, Tucker S I, Farr B M. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial.  JAMA. 1989;  261(6) 878-883
• 27 Trerotola S O, Johnson M S, Shah H et al.. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection—a randomized study.  Radiology. 1998;  207(2) 491-496
• 28 Bambauer R, Mestres P, Schiel R, Schneidewind-Muller J M, Bambauer S, Sioshansi P. Large bore catheters with surface treatments versus untreated catheters for blood access.  J Vasc Access. 2001;  2(3) 97-105
• 29 Lau C E. Transparent and gauze dressings and their effect on infection rates of central venous catheters: a review of past and current literature.  J Intraven Nurs. 1996;  19(5) 240-245
• 30 James M T, Conley J, Tonelli M, Manns B J, MacRae J, Hemmelgarn B R. Alberta Kidney Disease Network . Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.  Ann Intern Med. 2008;  148(8) 596-605
• 31 Dialysis Outcomes Quality Initiative (DOQI) .Clinical Practice Guidelines for Vascular Access. 
• 32 Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials.  Clin Infect Dis. 2008;  47(1) 83-93
• 33 Silva J, Teixeira e Costa, Baptista A, Ramos A, Ponce P. Catheter-related bactermia in hemodialysis: which preventive measures to take?.  Nephron Clin Pract. 2008;  110(4) c251-c257
• 34 Onder A M, Chandar J, Simon N et al.. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.  Pediatr Nephrol. 2008;  23(3) 457-464
• 35 Falagas M E, Fragoulis K, Bliziotis I A, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.  J Antimicrob Chemother. 2007;  59(3) 359-369
• 36 Halton K, Graves N. Economic evaluation and catheter-related bloodstream infections.  Emerg Infect Dis. 2007;  13(6) 815-823
• 37 Lumsden A. A unique combination technology of ePTFE and proprietary end-point covalent bonding of heparin for lower extremity revascularization: the GORE PROPATEN vascular graft.  Vasc Dis Manag. 2007;  4(Suppl. B) 11B-14B
• 38 Jain G, Allon M, Maya I. Retrospective comparison of heparin-coated and non-coated tunneled dialysis catheters.  ASN. 2008;  , Renal week abstract presentation
• 39 Trerotola S O, Shah H, Johnson M et al.. Randomized comparison of high-flow versus conventional hemodialysis catheters.  J Vasc Interv Radiol. 1999;  10(8) 1032-1038
• 40 Warren S E, O'Connor D T, Steinberg S M. Recirculation: a uremic syndrome complicating the use of prosthetic arteriovenous fistulas for hemodialysis.  J Dial. 1978;  2(3) 251-259
• 41 Senécal L, Saint-Sauveur E, Leblanc M. Blood flow and recirculation rates in tunneled hemodialysis catheters.  ASAIO J. 2004;  50(1) 94-97
• 42 O'Dwyer H, Fotheringham T, O'Kelly P et al.. A prospective comparison of two types of tunneled hemodialysis catheters: the Ash Split versus the PermCath.  Cardiovasc Intervent Radiol. 2005;  28(1) 23-29
• 43 Van Ha T, Santeler S, Lorenz J et al.. Comparison between the split-tip catheter and non split-tip catheter for hemodialysis.  J Vasc Interv Radiol. 2007;  18(suppl 1) S45
• 44 Tal M G, Peixoto A J, Crowley S T, Denbow N, Eliseo D, Pollak J. Comparison of side hole versus non side hole high flow hemodialysis catheters.  Hemodial Int. 2006;  10(1) 63-67
• 45 Fuchs S, Pollak A, Gilon D. Central venous catheter mechanical irritation of the right atrial free Wall:A cause for thrombus formation.  Cardiology. 1999;  91(3) 169-172
• 46 Ross J. Optimizing catheter tip positioning.  Endovasc Today. 2003;  2 32-34
• 47 Davanzo W J. Efficacy and safety of a retrograde tunneled hemodialysis catheter: 6-month clinical experience with the Cannon Catheter chronic hemodialysis catheter.  J Vasc Access. 2005;  6(1) 38-44
• 48 Tal M G. Comparison of recirculation percentage of the palindrome catheter and standard hemodialysis catheters in a swine model.  J Vasc Interv Radiol. 2005;  16(9) 1237-1240
• 49 Spector M, Mojibian H, Eliseo D et al.. Clinical outcome of the Tal Palindrome chronic hemodialysis catheter: single institution experience.  J Vasc Interv Radiol. 2008;  19(10) 1434-1438
• 50 Tokars J I, Finelli L, Alter M J, Arduino M J. National surveillance of dialysis-associated diseases in the United States, 2001.  Semin Dial. 2004;  17(4) 310-319
• 51 Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis.  Am J Kidney Dis. 2004;  44(5) 779-791